MedTrace Logo

DLBCL Treatment in Children and Adolescents

NCT04726995 路 Status: COMPLETED 路 Type: OBSERVATIONAL 路 Enrollment: 106

Last updated 2021-01-27

No results posted yet for this study

Summary

We compared the efficacy and safety of modified NHL-BFM-90 regimen and R-CHOP/CHOP regimen in pediatric (aged 0-14 years) and adolescent锛坅ged 15-18 years锛塂LBCL patients in a single institution during a 20-year period. we compared the efficacy and safety of modified NHL-BFM-90 regimen and R-CHOP/CHOP regimen in pediatric (aged 0-14 years) and adolescent锛坅ged 15-18 years锛塂LBCL patients in a single institution during a 20-year period. To our best knowledge, no reports have been previously published regarding the comparison.

Conditions

  • Diffuse Large B-cell Lymphoma

Interventions

OTHER

CHOP and BFM regiments

used CHOP and BFM regiments

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Yizhuo Zhang 路 Sun Yat-sen University CancerCenter

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2020-05-31
Completion
2020-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04726995 on ClinicalTrials.gov